0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Portal Hypertension Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-3O13578
Home | Market Reports | Health| Pharmacy
Global Portal Hypertension Market Insights Forecast to 2029
BUY CHAPTERS

Global Portal Hypertension Market Research Report 2025

Code: QYRE-Auto-3O13578
Report
May 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Portal Hypertension Market

The global market for Portal Hypertension was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Portal Hypertension is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Portal Hypertension is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Portal Hypertension include Novartis AG, Gilead Sciences Inc., Sun Pharmaceuticals Industries Ltd., United Therapeutics Corporation, Ono Pharmaceutical Co., Ltd., Genextra S.p.a., Chiasma Inc, Dr. Falk Pharma GmbH, Debiovision, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Portal Hypertension, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Portal Hypertension.
The Portal Hypertension market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Portal Hypertension market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Portal Hypertension manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Portal Hypertension Market Report

Report Metric Details
Report Name Portal Hypertension Market
Segment by Type
  • Medication
  • Endoscopic Therapy
  • Shunting Procedures
  • Liver Transplantation
Segment by Application
  • Hospital
  • Specialist Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis AG, Gilead Sciences Inc., Sun Pharmaceuticals Industries Ltd., United Therapeutics Corporation, Ono Pharmaceutical Co., Ltd., Genextra S.p.a., Chiasma Inc, Dr. Falk Pharma GmbH, Debiovision, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Portal Hypertension manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Portal Hypertension in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Portal Hypertension Market report?

Ans: The main players in the Portal Hypertension Market are Novartis AG, Gilead Sciences Inc., Sun Pharmaceuticals Industries Ltd., United Therapeutics Corporation, Ono Pharmaceutical Co., Ltd., Genextra S.p.a., Chiasma Inc, Dr. Falk Pharma GmbH, Debiovision, Inc.

What are the Application segmentation covered in the Portal Hypertension Market report?

Ans: The Applications covered in the Portal Hypertension Market report are Hospital, Specialist Clinic, Others

What are the Type segmentation covered in the Portal Hypertension Market report?

Ans: The Types covered in the Portal Hypertension Market report are Medication, Endoscopic Therapy, Shunting Procedures, Liver Transplantation

1 Portal Hypertension Market Overview
1.1 Product Definition
1.2 Portal Hypertension by Type
1.2.1 Global Portal Hypertension Market Value Comparison by Type (2024 VS 2031)
1.2.2 Medication
1.2.3 Endoscopic Therapy
1.2.4 Shunting Procedures
1.2.5 Liver Transplantation
1.3 Portal Hypertension by Application
1.3.1 Global Portal Hypertension Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Global Portal Hypertension Market Size Estimates and Forecasts
1.4.1 Global Portal Hypertension Revenue 2020-2031
1.4.2 Global Portal Hypertension Sales 2020-2031
1.4.3 Global Portal Hypertension Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Portal Hypertension Market Competition by Manufacturers
2.1 Global Portal Hypertension Sales Market Share by Manufacturers (2020-2025)
2.2 Global Portal Hypertension Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Portal Hypertension Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Portal Hypertension, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Portal Hypertension, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Portal Hypertension, Product Type & Application
2.7 Global Key Manufacturers of Portal Hypertension, Date of Enter into This Industry
2.8 Global Portal Hypertension Market Competitive Situation and Trends
2.8.1 Global Portal Hypertension Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Portal Hypertension Players Market Share by Revenue
2.8.3 Global Portal Hypertension Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Portal Hypertension Market Scenario by Region
3.1 Global Portal Hypertension Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Portal Hypertension Sales by Region: 2020-2031
3.2.1 Global Portal Hypertension Sales by Region: 2020-2025
3.2.2 Global Portal Hypertension Sales by Region: 2026-2031
3.3 Global Portal Hypertension Revenue by Region: 2020-2031
3.3.1 Global Portal Hypertension Revenue by Region: 2020-2025
3.3.2 Global Portal Hypertension Revenue by Region: 2026-2031
3.4 North America Portal Hypertension Market Facts & Figures by Country
3.4.1 North America Portal Hypertension Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Portal Hypertension Sales by Country (2020-2031)
3.4.3 North America Portal Hypertension Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Portal Hypertension Market Facts & Figures by Country
3.5.1 Europe Portal Hypertension Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Portal Hypertension Sales by Country (2020-2031)
3.5.3 Europe Portal Hypertension Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Portal Hypertension Market Facts & Figures by Region
3.6.1 Asia Pacific Portal Hypertension Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Portal Hypertension Sales by Region (2020-2031)
3.6.3 Asia Pacific Portal Hypertension Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Portal Hypertension Market Facts & Figures by Country
3.7.1 Latin America Portal Hypertension Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Portal Hypertension Sales by Country (2020-2031)
3.7.3 Latin America Portal Hypertension Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Portal Hypertension Market Facts & Figures by Country
3.8.1 Middle East and Africa Portal Hypertension Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Portal Hypertension Sales by Country (2020-2031)
3.8.3 Middle East and Africa Portal Hypertension Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Portal Hypertension Sales by Type (2020-2031)
4.1.1 Global Portal Hypertension Sales by Type (2020-2025)
4.1.2 Global Portal Hypertension Sales by Type (2026-2031)
4.1.3 Global Portal Hypertension Sales Market Share by Type (2020-2031)
4.2 Global Portal Hypertension Revenue by Type (2020-2031)
4.2.1 Global Portal Hypertension Revenue by Type (2020-2025)
4.2.2 Global Portal Hypertension Revenue by Type (2026-2031)
4.2.3 Global Portal Hypertension Revenue Market Share by Type (2020-2031)
4.3 Global Portal Hypertension Price by Type (2020-2031)
5 Segment by Application
5.1 Global Portal Hypertension Sales by Application (2020-2031)
5.1.1 Global Portal Hypertension Sales by Application (2020-2025)
5.1.2 Global Portal Hypertension Sales by Application (2026-2031)
5.1.3 Global Portal Hypertension Sales Market Share by Application (2020-2031)
5.2 Global Portal Hypertension Revenue by Application (2020-2031)
5.2.1 Global Portal Hypertension Revenue by Application (2020-2025)
5.2.2 Global Portal Hypertension Revenue by Application (2026-2031)
5.2.3 Global Portal Hypertension Revenue Market Share by Application (2020-2031)
5.3 Global Portal Hypertension Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Company Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Portal Hypertension Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis AG Portal Hypertension Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Gilead Sciences Inc.
6.2.1 Gilead Sciences Inc. Company Information
6.2.2 Gilead Sciences Inc. Description and Business Overview
6.2.3 Gilead Sciences Inc. Portal Hypertension Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gilead Sciences Inc. Portal Hypertension Product Portfolio
6.2.5 Gilead Sciences Inc. Recent Developments/Updates
6.3 Sun Pharmaceuticals Industries Ltd.
6.3.1 Sun Pharmaceuticals Industries Ltd. Company Information
6.3.2 Sun Pharmaceuticals Industries Ltd. Description and Business Overview
6.3.3 Sun Pharmaceuticals Industries Ltd. Portal Hypertension Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sun Pharmaceuticals Industries Ltd. Portal Hypertension Product Portfolio
6.3.5 Sun Pharmaceuticals Industries Ltd. Recent Developments/Updates
6.4 United Therapeutics Corporation
6.4.1 United Therapeutics Corporation Company Information
6.4.2 United Therapeutics Corporation Description and Business Overview
6.4.3 United Therapeutics Corporation Portal Hypertension Sales, Revenue and Gross Margin (2020-2025)
6.4.4 United Therapeutics Corporation Portal Hypertension Product Portfolio
6.4.5 United Therapeutics Corporation Recent Developments/Updates
6.5 Ono Pharmaceutical Co., Ltd.
6.5.1 Ono Pharmaceutical Co., Ltd. Company Information
6.5.2 Ono Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Ono Pharmaceutical Co., Ltd. Portal Hypertension Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ono Pharmaceutical Co., Ltd. Portal Hypertension Product Portfolio
6.5.5 Ono Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Genextra S.p.a.
6.6.1 Genextra S.p.a. Company Information
6.6.2 Genextra S.p.a. Description and Business Overview
6.6.3 Genextra S.p.a. Portal Hypertension Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Genextra S.p.a. Portal Hypertension Product Portfolio
6.6.5 Genextra S.p.a. Recent Developments/Updates
6.7 Chiasma Inc
6.7.1 Chiasma Inc Company Information
6.7.2 Chiasma Inc Description and Business Overview
6.7.3 Chiasma Inc Portal Hypertension Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chiasma Inc Portal Hypertension Product Portfolio
6.7.5 Chiasma Inc Recent Developments/Updates
6.8 Dr. Falk Pharma GmbH
6.8.1 Dr. Falk Pharma GmbH Company Information
6.8.2 Dr. Falk Pharma GmbH Description and Business Overview
6.8.3 Dr. Falk Pharma GmbH Portal Hypertension Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Dr. Falk Pharma GmbH Portal Hypertension Product Portfolio
6.8.5 Dr. Falk Pharma GmbH Recent Developments/Updates
6.9 Debiovision, Inc.
6.9.1 Debiovision, Inc. Company Information
6.9.2 Debiovision, Inc. Description and Business Overview
6.9.3 Debiovision, Inc. Portal Hypertension Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Debiovision, Inc. Portal Hypertension Product Portfolio
6.9.5 Debiovision, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Portal Hypertension Industry Chain Analysis
7.2 Portal Hypertension Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Portal Hypertension Production Mode & Process Analysis
7.4 Portal Hypertension Sales and Marketing
7.4.1 Portal Hypertension Sales Channels
7.4.2 Portal Hypertension Distributors
7.5 Portal Hypertension Customer Analysis
8 Portal Hypertension Market Dynamics
8.1 Portal Hypertension Industry Trends
8.2 Portal Hypertension Market Drivers
8.3 Portal Hypertension Market Challenges
8.4 Portal Hypertension Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Portal Hypertension Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Portal Hypertension Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Portal Hypertension Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Portal Hypertension Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Portal Hypertension Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Portal Hypertension Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Portal Hypertension Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Portal Hypertension Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Portal Hypertension, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Portal Hypertension, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Portal Hypertension, Product Type & Application
 Table 12. Global Key Manufacturers of Portal Hypertension, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Portal Hypertension by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Portal Hypertension as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Portal Hypertension Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Portal Hypertension Sales by Region (2020-2025) & (K Units)
 Table 18. Global Portal Hypertension Sales Market Share by Region (2020-2025)
 Table 19. Global Portal Hypertension Sales by Region (2026-2031) & (K Units)
 Table 20. Global Portal Hypertension Sales Market Share by Region (2026-2031)
 Table 21. Global Portal Hypertension Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Portal Hypertension Revenue Market Share by Region (2020-2025)
 Table 23. Global Portal Hypertension Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Portal Hypertension Revenue Market Share by Region (2026-2031)
 Table 25. North America Portal Hypertension Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Portal Hypertension Sales by Country (2020-2025) & (K Units)
 Table 27. North America Portal Hypertension Sales by Country (2026-2031) & (K Units)
 Table 28. North America Portal Hypertension Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Portal Hypertension Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Portal Hypertension Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Portal Hypertension Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Portal Hypertension Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Portal Hypertension Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Portal Hypertension Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Portal Hypertension Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Portal Hypertension Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Portal Hypertension Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Portal Hypertension Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Portal Hypertension Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Portal Hypertension Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Portal Hypertension Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Portal Hypertension Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Portal Hypertension Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Portal Hypertension Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Portal Hypertension Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Portal Hypertension Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Portal Hypertension Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Portal Hypertension Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Portal Hypertension Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Portal Hypertension Sales (K Units) by Type (2020-2025)
 Table 51. Global Portal Hypertension Sales (K Units) by Type (2026-2031)
 Table 52. Global Portal Hypertension Sales Market Share by Type (2020-2025)
 Table 53. Global Portal Hypertension Sales Market Share by Type (2026-2031)
 Table 54. Global Portal Hypertension Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Portal Hypertension Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Portal Hypertension Revenue Market Share by Type (2020-2025)
 Table 57. Global Portal Hypertension Revenue Market Share by Type (2026-2031)
 Table 58. Global Portal Hypertension Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Portal Hypertension Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Portal Hypertension Sales (K Units) by Application (2020-2025)
 Table 61. Global Portal Hypertension Sales (K Units) by Application (2026-2031)
 Table 62. Global Portal Hypertension Sales Market Share by Application (2020-2025)
 Table 63. Global Portal Hypertension Sales Market Share by Application (2026-2031)
 Table 64. Global Portal Hypertension Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Portal Hypertension Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Portal Hypertension Revenue Market Share by Application (2020-2025)
 Table 67. Global Portal Hypertension Revenue Market Share by Application (2026-2031)
 Table 68. Global Portal Hypertension Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Portal Hypertension Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis AG Company Information
 Table 71. Novartis AG Description and Business Overview
 Table 72. Novartis AG Portal Hypertension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis AG Portal Hypertension Product
 Table 74. Novartis AG Recent Developments/Updates
 Table 75. Gilead Sciences Inc. Company Information
 Table 76. Gilead Sciences Inc. Description and Business Overview
 Table 77. Gilead Sciences Inc. Portal Hypertension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Gilead Sciences Inc. Portal Hypertension Product
 Table 79. Gilead Sciences Inc. Recent Developments/Updates
 Table 80. Sun Pharmaceuticals Industries Ltd. Company Information
 Table 81. Sun Pharmaceuticals Industries Ltd. Description and Business Overview
 Table 82. Sun Pharmaceuticals Industries Ltd. Portal Hypertension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sun Pharmaceuticals Industries Ltd. Portal Hypertension Product
 Table 84. Sun Pharmaceuticals Industries Ltd. Recent Developments/Updates
 Table 85. United Therapeutics Corporation Company Information
 Table 86. United Therapeutics Corporation Description and Business Overview
 Table 87. United Therapeutics Corporation Portal Hypertension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. United Therapeutics Corporation Portal Hypertension Product
 Table 89. United Therapeutics Corporation Recent Developments/Updates
 Table 90. Ono Pharmaceutical Co., Ltd. Company Information
 Table 91. Ono Pharmaceutical Co., Ltd. Description and Business Overview
 Table 92. Ono Pharmaceutical Co., Ltd. Portal Hypertension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Ono Pharmaceutical Co., Ltd. Portal Hypertension Product
 Table 94. Ono Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 95. Genextra S.p.a. Company Information
 Table 96. Genextra S.p.a. Description and Business Overview
 Table 97. Genextra S.p.a. Portal Hypertension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Genextra S.p.a. Portal Hypertension Product
 Table 99. Genextra S.p.a. Recent Developments/Updates
 Table 100. Chiasma Inc Company Information
 Table 101. Chiasma Inc Description and Business Overview
 Table 102. Chiasma Inc Portal Hypertension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Chiasma Inc Portal Hypertension Product
 Table 104. Chiasma Inc Recent Developments/Updates
 Table 105. Dr. Falk Pharma GmbH Company Information
 Table 106. Dr. Falk Pharma GmbH Description and Business Overview
 Table 107. Dr. Falk Pharma GmbH Portal Hypertension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Dr. Falk Pharma GmbH Portal Hypertension Product
 Table 109. Dr. Falk Pharma GmbH Recent Developments/Updates
 Table 110. Debiovision, Inc. Company Information
 Table 111. Debiovision, Inc. Description and Business Overview
 Table 112. Debiovision, Inc. Portal Hypertension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Debiovision, Inc. Portal Hypertension Product
 Table 114. Debiovision, Inc. Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Portal Hypertension Distributors List
 Table 118. Portal Hypertension Customers List
 Table 119. Portal Hypertension Market Trends
 Table 120. Portal Hypertension Market Drivers
 Table 121. Portal Hypertension Market Challenges
 Table 122. Portal Hypertension Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Portal Hypertension
 Figure 2. Global Portal Hypertension Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Portal Hypertension Market Share by Type: 2024 & 2031
 Figure 4. Medication Product Picture
 Figure 5. Endoscopic Therapy Product Picture
 Figure 6. Shunting Procedures Product Picture
 Figure 7. Liver Transplantation Product Picture
 Figure 8. Global Portal Hypertension Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Portal Hypertension Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Specialist Clinic
 Figure 12. Others
 Figure 13. Global Portal Hypertension Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Portal Hypertension Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Portal Hypertension Sales (2020-2031) & (K Units)
 Figure 16. Global Portal Hypertension Average Price (US$/Unit) & (2020-2031)
 Figure 17. Portal Hypertension Report Years Considered
 Figure 18. Portal Hypertension Sales Share by Manufacturers in 2024
 Figure 19. Global Portal Hypertension Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Portal Hypertension Players: Market Share by Revenue in Portal Hypertension in 2024
 Figure 21. Portal Hypertension Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Portal Hypertension Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Portal Hypertension Sales Market Share by Country (2020-2031)
 Figure 24. North America Portal Hypertension Revenue Market Share by Country (2020-2031)
 Figure 25. United States Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Portal Hypertension Sales Market Share by Country (2020-2031)
 Figure 28. Europe Portal Hypertension Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Portal Hypertension Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Portal Hypertension Revenue Market Share by Region (2020-2031)
 Figure 36. China Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Portal Hypertension Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Portal Hypertension Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Portal Hypertension Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Portal Hypertension Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Portal Hypertension Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Portal Hypertension by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Portal Hypertension by Type (2020-2031)
 Figure 55. Global Portal Hypertension Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Portal Hypertension by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Portal Hypertension by Application (2020-2031)
 Figure 58. Global Portal Hypertension Price (US$/Unit) by Application (2020-2031)
 Figure 59. Portal Hypertension Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart